Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence

Nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale and warrants urgent investigation of its therapeutic potential, for COVID-19-induced acute respiratory distress syndrome (ARDS). COVID-19 ARDS displays the typical features of diffuse alveolar damage with extensi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Haren, Frank M. P., Page, Clive, Laffey, John G., Artigas, Antonio, Camprubi-Rimblas, Marta, Nunes, Quentin, Smith, Roger, Shute, Janis, Carroll, Mary, Tree, Julia, Carroll, Miles, Singh, Dave, Wilkinson, Tom, Dixon, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374660/
https://www.ncbi.nlm.nih.gov/pubmed/32698853
http://dx.doi.org/10.1186/s13054-020-03148-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374660/
https://www.ncbi.nlm.nih.gov/pubmed/32698853
http://dx.doi.org/10.1186/s13054-020-03148-2

Ejemplares similares